Rose Limaye
Associate | London
Rose Limaye

Rose Limaye focuses her practice on corporate and securities matters with an emphasis on corporate transactions, including mergers and acquisitions, fundraisings, public offerings, and reorganizations.

Ms. Limaye joined Dechert in 2015 as a trainee and qualified in 2017.

  • ARK Invest in connection with the acquisition of Rize ETF Limited.
  • Chiesi Farmaceutici in connection with its proposed US$1.48 billion acquisition of Amryt Pharma PLC by way of Scheme of Arrangement.
  • One of the world's largest asset managers in connection with its Series E investment in one of Europe's leading mobility platforms.
  • Nordic Capital on the purchase of a majority shareholding in Duco Technology Limited, a leading Software as a Service (SaaS) provider to financial institutions, insurers and FinTech companies worldwide.
  • ICTS International N.V. on a secondary sale of preferred equity of Au10tix Technologies by TPG to GF GW LLC and Oak and all related shareholder arrangements.
  • Nordic Capital on the EUR 2.143 billion sale of Itiviti, a leading provider of trading technology and services to financial institutions worldwide, to NYSE listed Broadridge Financial Solutions, Inc.
  • Blackstone Credit (formerly GSO Capital Partners) on the acquisition of Co-operative Group’s general insurance business by GSO, TwinFocus and Markerstudy Group.
  • Bentley Systems in connection with the acquisition of SRO Solutions Holdings Limited and the assets of DXSTRO Software LLP.
  • Corimar Asset Management Fund LP on the sale of certain business assets of Frobisher Capital Limited to Wren Sterling.
  • Canaccord Genuity Limited in connection with an equity fundraising by Mirriad Advertising plc.
  • Bentley Systems in connection with the acquisition of Professional Construction Strategies Group Ltd, a UK-based digital built-environment consultancy.
  • Investec Bank plc in connection with a £172 million equity fundraising by ITM Power plc.
  • Seamus Lynch on its sale of a majority stake in Chill Insurance Group to Livingbridge.
  • Investcorp, a leading global manager of alternative investments, and Tages, a leading European alternative asset management firm, in connection with a 50/50 joint venture and contribution of their subsequent merger of the Absolute Return businesses to create Investcorp-Tages Limited.
  • Bentley Systems, a leading global provider of software services in connection with the acquisition of GroupBC, a UK-based SaaS software and cloud services business.
  • Share plc, the LSE listed holding company for The Share Centre, one of the UK's leading independent retail stockbrokers, on its £62 million takeover by Interactive Investor, the UK's second largest direct to consumer investment platform, which is majority owned by J.C. Flowers IV, L.P., a fund advised by J.C. Flowers & Co, LLC, a leading private investment firm.
  • Cerberus Capital Management on the sale of Covis Pharma to Apollo Global Management.
  • Judges Scientific plc on the acquisition of Moorfield Nanotechnology Limited, a manufacturer of scientific instruments.
  • ArchiMed on the acquisition of Direct Healthcare Group from NorthEdge Capital.
  • TRS Group (UK) Limited, a family owned food business, on the sale of (i) TRS Wholesale Co. Limited (ii) TRS Cash & Carry Limited and (iii) TRS International Foods Limited to Cricket Bidco Limited, a subsidiary of a fund managed by Exponent Private Equity LLP.
  • Investec Bank plc in connection with a £58.5 million equity fundraising by ITM Power plc and joint venture with Linde AG. 
  • A substantial family office as investor in a substantive venture investment in a UK ticketing and events hosting company.
  • Merck KGaA, as deal counsel on the restructure of its ongoing collaboration and acquisition option arrangements with F-Star.
  • Stripes Group on the sale of its portfolio company Audio Network Limited to Entertainment One Limited.
  • One Equity Partners on the acquisition of the MERA group, a custom software developments services provider.
  • Quilvest Private Equity on the acquisition of global specialist recruitment firm Phaidon International.
  • Prexton Therapeutics B.V. and its selling shareholders, including M Ventures, in its sale to global pharmaceutical company H. Lundbeck A/S for up to €905 million.
  • The shareholders on the sale of Stat-Dx, a privately owned Spanish diagnostics company, to QIAGEN N.V., for US$191 million (including milestones).  


Services Industries
    • University of Oxford, B.A., 2014
    • University of Law, Legal Practice Course, 2015
    • England and Wales, 2017